NEW YORK – Proteomics firm Seer said on Monday that it is planning an offering of 3.5 million shares of Class A common stock.
The proposed offering will consist of 1.4 million shares sold by Seer and 2.1 million shares sold by stockholders of Seer. Additionally, the selling stockholders will grant the underwriters a 30-day option to purchase up to 525,000 additional shares of Class A common stock at the public offering price, less underwriting discounts and commissions.